Evolent Health
EVH
199 hedge funds and large institutions have $608M invested in Evolent Health in 2026 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 68 increasing their positions, 64 reducing their positions, and 30 closing their positions.
141% more capital invested
Capital invested by funds: $253M → $608M (+$356M)
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
27% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 30
4% more funds holding
Funds holding: 192 → 199 (+7)
6% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 64
0.61% more ownership
Funds ownership: 99.24% → 99.84% (+0.61%)
47% less call options, than puts
Call options by funds: $1.06M | Put options by funds: $2.01M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$15.1M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
+$11M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$10.1M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$4.9M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$7.3M |
| 2 |
Jane Street
New York
|
-$6.86M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
-$5.87M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$5.81M |
| 5 |
TC
Tejara Capital
London,
United Kingdom
|
-$5.77M |
EVH Hedge Fund Activity: Q2 2026 in Review
199 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q2 2026, worth a combined $608M — up 141% from $253M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new EVH positions and 30 closed out — a net gain of 8 holders — while 68 added to existing stakes and 64 trimmed.
The largest buyer was BlackRock, adding an estimated $15.1M. The largest seller was UBS Group, cutting an estimated $7.3M.
- 199 institutional investors held Evolent Health (EVH) as of Q2 2026, up from 192 in Q1 2026.
- Funds reported $608M of Evolent Health stock for Q2 2026, up 141% quarter-over-quarter.
- 38 funds opened new Evolent Health positions in Q2 2026 and 30 closed out, a net change of +8 holders.
- The largest Evolent Health buyer in Q2 2026 was BlackRock, an estimated $15.1M added.
- The largest Evolent Health seller in Q2 2026 was UBS Group, an estimated $7.3M sold.
Based on aggregated 13F filings for Q2 2026.